02 FDA批准5至11岁儿童接种辉瑞疫苗

The US Food and Drug Administration has authorised the use of the BioNTech/Pfizer Covid-19 vaccine for children aged five to 11 years, paving the way for the US to become the first country in the world to green light that jab for younger children.

美国食品和药物管理局已批准辉瑞为5至11岁儿童使用新冠疫苗，这为美国成为世界上第一个批准低龄儿童接种该疫苗的国家铺平了道路。

The agency said its emergency use authorisation was based on a “thorough and transparent”evaluation of safety and efficacy data, which showed the vaccine was 90.7 per cent effective at preventing Covid-19 in children within the age group.

该机构表示，其紧急使用授权是基于对安全性和有效性数据的“彻底和透明”评估。评估显示，该疫苗在预防该年龄段儿童感染Covid-19方面的有效性为90.7%。

Advisers at the Centers for Disease Control and Prevention will meet next week to discuss further clinical recommendations and guidelines for a proposed nationwide roll out of jabs.The US has about 28m children aged between five and 11. However, authorities may face a battle to persuade families to bring their children for jabs. A recent survey by the Kaiser Family Foundation showed almost a third of parents would “definitely” not get their kids vaccinated.

美国疾病控制与预防中心本周将讨论进一步的临床建议和指导方针，以便在全国范围内推广疫苗接种。美国约有2800万5至11岁的儿童。然而，当局可能会面临一场劝说家庭带孩子去接种疫苗的斗争。凯泽家庭基金会的一项调查显示，几乎三分之一的父母“肯定”不会给孩子接种疫苗。